Drug
Canosimibe clinical trials
Also written AVE5530.
How studies write it
Studies that test it under each name
Development codes
- AVE5530
- 4
Studies by the year they started
4 studies that test it; most in 2008 (3)
| Year | Studies |
|---|---|
| 2007 | 1 |
| 2008 | 3 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses canosimibe is read from its arms, and is right about nine times in ten.
Testing it · 4
- Evaluation of Efficacy and Safety of AVE5530 in Patients With Primary HypercholesterolemiaTerminatedPhase 3SanofiNCT00718965Written as AVE5530
- Evaluation of Safety and Efficacy of AVE5530 as add-on to Ongoing High Doses of Statins in Patients With Primary Severe HypercholesterolemiaTerminatedPhase 3SanofiNCT00766688Written as AVE5530
- Evaluation of Efficacy and Safety of AVE5530 Co-administered With Atorvastatin in Primary HypercholesterolemiaTerminatedPhase 3SanofiNCT00741715Written as AVE5530
- A Study Evaluating the Safety and Efficacy of AVE5530 (4 Weeks) in Patients With Mild to Moderate HypercholesterolemiaCompletedPhase 2SanofiNCT00440154Written as AVE5530
Codes
What other systems call canosimibe · ClinicalTrials.gg INT014477
- UNII (FDA) 2GG0K1I5CICANOSIMIBEConfirmed FDA, Wikidata
- Wikidata Q27254713canosimibeConfirmed FDA, Wikidata
- NCI Thesaurus C91027CanosimibeOne source FDA
- DrugBank DB19723One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 2GG0K1I5CI | CANOSIMIBE | Confirmed FDA, Wikidata |
| Wikidata | Q27254713 | canosimibe | Confirmed FDA, Wikidata |
| NCI Thesaurus | C91027 | Canosimibe | One source FDA |
| DrugBank | DB19723 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.